Published On: October 27th, 2010
At a time when cash-strapped U.S. patients are deserting their prescriptions due to sticker shock and debt-laden European governments are trying to control price increases, antiviral agents are giving pharmaceutical executives hope of serious revenue increases.
Read the rest here:
Bristol-Myers Squibb Sees Growth in Antiviral Therapies
Loading...
Leave a comment



Did you know:



